Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT05145725
Recruiting Observational

Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis

NCT05145725 · tracked via the Priya Life Science France tracker
Sponsor
Phase
Observational
Started
2021-03-18
Last updated
2024-02-29

Condition(s) studied

Scoliosis; AdolescenceArthrodesis

Investigational drug(s) / intervention(s)

Quality of life questionnaires

Quality of life questionnaires: Different questionnaires to fill : SRS-22r, SF-36 score, TAPS, KIDSCREEN10

Study summary

The study population concerns adolescent patients with idiopathic scoliosis which requires surgical management and who have a longer waiting period of 6 months.

The aim of this study is to research the predictive factors of an improvement in the quality of life of adolescents who have had surgery.

Eligibility

Sex
ALL
Min age
12 Years
Max age
20 Years
Healthy volunteers
No
Inclusion Criteria: * Patient between 12 and 20 years old * Scoliosis in adolescents for whom surgery has been proposed based on radiological criteria (Cobb angle\> 25 ° for thoracolumbar and lumbar scoliosis,\> 35 ° for thoracic scoliosis and\> 40 ° for double major scoliosis) * Patient affiliated or beneficiary of a social security scheme or attached to a beneficiary of a social security scheme * Patient and legal representative having been informed and not opposing this research Exclusion Criteria: * Patient over 20 years old * Non-surgical scoliosis * Refusal to participate in the study by the child or parents

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinique du dos Bruges France Recruiting

More Elsan trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05145725 on ClinicalTrials.gov ↗ ← All trials in France